AMPK/cAMP代谢信号轴作为糖尿病的可能治疗标
José Augusto Nogueira-Machado1, Nathália Augusta Gomes2, Fabiana Rocha-Silva1
1Programa de Pós-Graduação Stricto Sensu em Medicina/Biomedicina, Faculdade de Saúde Santa Casa de BH, Belo Horizonte, Minas Gerais, Brazil.
Current molecular medicine
|September 10, 2024
概括
本综述探讨了循环AMP/AMPK轴作为糖尿病潜在的治疗点. 了解它在代谢信号传递中的作用,可能会为这种复杂而渐进的疾病提供新的治疗方法.
科学领域:
- 内分泌学和新陈代谢学
- 分子信号传输的方法
- 糖尿病研究 糖尿病研究
背景情况:
- 糖尿病是一种渐进的,复杂的代谢疾病,对全球健康和经济造成重大负担.
- 目前的治疗方法可以治疗糖尿病,但不能逆转糖尿病或完全预防其并发症.
- 普遍存在的生活方式因素和延迟诊断使糖尿病管理复杂化.
研究的目的:
- 审查糖尿病中循环AMP (cAMP) /AMP激活蛋白激酶 (AMPK) 轴的代谢信号.
- 要突出cAMP/AMPK轴与高血糖诱导路径的相互联系.
- 确定cAMP/AMPK轴作为糖尿病潜在的治疗点.
主要方法:
- 文献综述,重点关注糖尿病中的代谢信号通路.
- 对高血糖,胰岛素抵抗和细胞信号传递的研究进行分析.
- 探索cAMP/AMPK轴在代谢调节中的作用.
主要成果:
- 高血糖影响复杂的细胞信号网络,包括胰岛素受体激活和抵抗.
- 循环AMP/AMPK轴与代谢调节有关,并显示出作为治疗点的前景.
- 现有的文献缺乏对高血糖引起的代谢网络及其与cAMP/AMPK轴的关系的全面探索.
结论:
- 在糖尿病治疗中,cAMP/AMPK轴代表了一个重要的,尚未探索的领域.
- 进一步研究cAMP/AMPK轴的代谢相互作用对于开发新的糖尿病治疗方法至关重要.
- 针对cAMP/AMPK途径可以提供新的策略来管理糖尿病进展和并发症.
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


